Latest From Biotech Now

The Costly Consequences of I-522

No-on-522-2 copy

Washington Research Council Reveals the Whole Story Behind Washington State’s Initiative 522, and Yes it Will Cost You a Dime Many Washington state residents know that on November 5, 2013, they will have to vote on whether or not to pass state Initiative 522, which will require special labels on certain foods made with genetically engineered (GE) ingredients.  What many residents don’t know is that a “yes” vote can lead to many costly consequences for Read More >

Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , , , , ,

JOBS Act Deconstructed: Regulation D

150639480

More than 40 biotech companies have gone public using provisions made available to emerging growth companies through the JOBS Act.  BIOtechNOW’s JOBS Act Deconstructed series will explore why it has had such an impact on biotech offerings and how emerging companies can leverage the new law to their best advantage.  Since the JOBS Act passed, attention has focused mostly on the law’s effects on the IPO market.  This is largely because the IPO On-Ramp was the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

New CDC Report on Alarming Rates of Antibiotic-Resistant Infections

MRSA

Every year in the United States, 2 million people acquire an antibiotic-resistant infection. Of those, at least 23,000 die as a result. That’s according to an alarming report  released last week by the CDC. Antibiotic resistance is one of the largest threats to global health. The prevalence of antibiotic-resistant infections is not only a serious world-wide public health issue, it also adds considerable costs to the U.S. healthcare system. According to the CDC: Studies have estimated Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Progress in Commercializing Advanced Biofuels and Renewable Chemicals

Pac_Rim115x75

The Biotechnology Industry Organization (BIO) yesterday announced breakout sessions for the upcoming 2013 Pacific Rim Summit on Industrial Biotechnology and Bioenergy.  Breakout session tracks are designed to showcase state-of-the-art advancements in the world of industrial biotech.  Attendees will have exclusive access to presentations from some of the most innovative companies in bioenergy and biobased chemicals including, Gevo, Inc., POET-DSM, Cool Planet Biofuels, and Abengoa Bioenergy US Holding, Inc. Brent Erickson, Executive Vice President of BIO’s Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

JOBS Act: Rule 506 Goes Into Effect Today

DC in Fall

Since Congress passed the Jumpstart our Business Startups (JOBS) Act last spring, there have been 39 IPOs in the biotech industry – and counting!  Today, another provision from the JOBS Act takes effect that will further enhance biotech capital formation. Pursuant to rules mandated by the JOBS Act, companies are now able to use general solicitation to advertise to investors when conducting an offering under Rule 506 of SEC Regulation D.  Rule 506 is a Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: ,